Here is my expert synthesis:
The single most promising near-term path to field-deployable blight-resistant American chestnut trees is The American Chestnut Foundation's recurrent genomic selection (RGS) program, which has now been validated by the landmark Westbrook et al. (2026) paper published in *Science*. RGS is TACF's main strategy for breeding disease resistance into American chestnut; it uses computer models to associate the DNA profile of a tree (genotype) with field-measured responses to disease such as canker size (phenotype). The method enables breeders to predict resistance from DNA alone, dramatically shortening generation intervals that previously required years of field inoculation trials. This new research shows that genomic tools can identify blight-resistant trees without waiting years for field testing, and scientists analyzing DNA from thousands of hybrid chestnut trees found that future generations could double current levels of blight resistance while retaining roughly 75% of American chestnut ancestry. Critically, large quantities of open-pollinated seeds will likely be available for restoration trials within 7 to 15 years. Meanwhile, the transgenic pathway remains in play but is fraught with complications: USDA completed its regulatory review of the Darling 54 American chestnut tree and issued a preliminary finding that it is "unlikely to pose a plant pest risk," but The American Chestnut Foundation had aided this project for about 10 years but withdrew its support in 2023, and the foundation's interim president stated the Darling 54's resistance "is not yet suitable to be used for restoration." The transgenic line still requires separate approvals from both the EPA and FDA, with timing not predictable for any of the agencies and the EPA review specifically potentially involving a multi-phased approval process. Given these uncertainties, the RGS breeding approach represents the most certain path to producing genetically diverse, regionally adapted, ecologically competitive trees at scale.
The most significant recent scientific development is the February 2026 publication by Westbrook et al. in *Science*, which fundamentally reframed the genetic architecture of blight resistance and validated genomic prediction as a tool for chestnut breeding. The study showed that, more than a century after two introduced pathogens killed billions of American chestnut trees, introgression of resistance alleles from Chinese chestnuts has contributed to recovery, but progress has been slow because of the complex genetic architecture of resistance. The study demonstrated that blight resistance is polygenic — not controlled by a few major-effect genes as the original Burnham hypothesis assumed — and that large-scale phenotyping and genotyping in hybrids confirmed that significant resistance gains are possible through selectively breeding trees with an average of 70 to 85% American chestnut ancestry. This matters enormously because it simultaneously explains why three decades of conventional backcross breeding yielded only intermediate resistance and provides a concrete path forward. Lead author Dr. Jared Westbrook stated: "With genome-enabled breeding, we expect the next generation of trees to have roughly twice the average blight resistance of our current population, with about 75 percent American chestnut ancestry." This paper also produced reference-quality genomes for both American and Chinese chestnut, comparing gene expression responses and stem metabolite profiles of the resistant Chinese and susceptible American chestnut species, resources that will underpin all future molecular breeding and potential gene-editing strategies for the species.
The biggest remaining bottlenecks are both institutional and biological. On the biological side, restoration of American chestnut depends on combining resistance to both the chestnut blight fungus (*Cryphonectria parasitica*) and *Phytophthora cinnamomi*, which causes Phytophthora root rot, in a diverse population. Forest landscape modeling has shown that root rot greatly reduced chestnut biomass on the landscape even when resistance was at the highest levels currently observed, and that warming climate enhanced the virulence of the pathogen, indicating restoration efforts will be more successful if targeted to latitudes, elevations, and site conditions where root rot is not expected to be present. The fact that alleles for resistance to *P. cinnamomi* and *C. parasitica* are not linked means that stacking both traits through breeding requires screening for two independent, polygenic suites of resistance — a task that is tractable with genomic selection but will take additional breeding cycles. Institutionally, the Darling 58/54 saga revealed deep fractures: in late October 2023, partners at the University of New England and University of Maine informed TACF of a possible pollen mix-up, and TACF independently confirmed that the OxO gene of all trees thought to be Darling 58 was on a different chromosome than expected. This eroded trust and split TACF's New York chapter into a separate nonprofit. TACF's own external grant program is currently paused, which limits the capacity to fund independent validation studies and ancillary research on silvicultural reintroduction techniques. The long generation times inherent in tree breeding — even with genomic acceleration — mean that sustained multi-decade institutional commitment is the single most critical enabling factor.
New funding would have its highest impact-per-dollar in three areas. First, scaling the genotyping and progeny-testing infrastructure of the RGS program is the most direct leverage point, because genomic selection allows accurate predictions of a tree's resistance from DNA alone as long as the tree is related to trees already evaluated in the field, and using the model, the most resistant parent trees can be selected for breeding. TACF's chapters, with their decades of experience growing chestnuts and many established field sites, are uniquely positioned to manage this network of replicated progeny tests, but expanding the number of field sites and the throughput of genotyping would accelerate the cycle from years to months per selection step. Second, dedicated investment in *Phytophthora cinnamomi* resistance screening is essential, since results demonstrate the vital importance of incorporating root rot resistance into the larger blight resistance breeding program, particularly given climate-change-driven northward expansion of the pathogen. Third, TACF has identified development of methods to optimize vegetative propagation (rooted cuttings and grafting) and methods to increase the efficiency of embryogenesis and induction of shoot apical meristems for genetic transformation and gene editing as priority research areas. Improving vegetative propagation would allow rapid clonal amplification of elite genotypes once identified, shortening the pipeline from genomic selection to field-ready nursery stock. These three investments — genotyping at scale, dual-pathogen screening, and propagation technology — together represent the highest-leverage portfolio for translating the genomic revolution documented in the 2026 *Science* paper into actual trees in the ground across the former range of this keystone species.